[Hemophagocytic syndrome in adult Still disease after initiation of sulfasalazine].
Pérez-De Pedro
I
I
Miranda-Candón
I
I
Camps-García
M T
MT
Gómez-Huelgas
R
R
D000328:Adult; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D051359:Lymphohistiocytosis, Hemophagocytic / Q000139:chemically induced*; D008297:Male; D016706:Still's Disease, Adult-Onset / Q000188:drug therapy*; D012460:Sulfasalazine / Q000009:adverse effects* / Q000627:therapeutic use
D018501:Antirheumatic Agents; D012460:Sulfasalazine